MRC1 and breast adenocarcinoma: Nanobodies against the macrophage mannose receptor (MMR) (CD206) were successfully used in SPECT imaging to specifically visualize a subpopulation of tumor-infiltrating macrophages in mammary adenocarcinoma and Lewis lung carcinoma models in mice [29].